About the Infographic
- A review of the approved PARP inhibitors showcased at ESMO 2022
- The progression of ATR inhibitors towards a regulatory approval
- DDR-relevant drug mechanisms of action
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements